Costs of urinary incontinence and overactive bladder in the United States: A comparative study
Costs of urinary incontinence and overactive bladder in the United States: A comparative study
复制标题
DOI：
10.1016/j.urology.2003.10.037
复制
发表时间：
2004-03-01
期刊：
影响因子：
2.1
通讯作者：
Hunt, T
中科院分区：
文献类型：
--
作者：
Hu, TW;Wagner, TH;Hunt, T
目标.更新2000年尿失禁（UI）的费用，并与膀胱过度活动症（OAB）的费用进行比较。使用疾病成本框架，将疾病流行病学数据与治疗率，后果概率和平均成本估计相结合。所有费用均反映2000年期间的费用。UI和OAB的总成本分别为195亿美元和126亿美元（2000年美元）。在UI中，社区居民承担了142亿美元，机构居民承担了53亿美元。与OAB，$9.1和$3.5十亿，分别由社区和机构居民。OAB影响了3400万人，而UI影响了1700万人。尽管在流行病学上存在差异，但UI的总成本和人均成本高于OAB成本，因为平均而言，没有失禁发作的OAB个体的成本较低。
Objectives. To update the cost of urinary incontinence (UI) for year 2000 and compare it with the cost of overactive bladder (OAB).Methods. Using the cost-of-illness framework, disease epidemiologic data were combined with treatment rates, consequence probabilities, and average cost estimates. All costs reflect the costs during 2000.Results. The total cost of UI and OAB was $19.5 billion and $12.6 billion, respectively (year 2000 dollars). With UI, $14.2 billion was borne by community residents and $5.3 billion by institutional residents. With OAB, $9.1 and $3.5 billion, respectively, was incurred by community and institutional residents.Conclusions. OAB affected 34 million individuals compared with 17 million with UI. Despite the differences in epidemiology, the total and per-person costs of UI were higher than the OAB costs because OAB individuals without incontinent episodes incurred fewer costs, on average.